Paul D. Light

1.1k total citations
26 papers, 871 citations indexed

About

Paul D. Light is a scholar working on Nephrology, Molecular Biology and Economics and Econometrics. According to data from OpenAlex, Paul D. Light has authored 26 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 4 papers in Molecular Biology and 3 papers in Economics and Econometrics. Recurrent topics in Paul D. Light's work include Dialysis and Renal Disease Management (9 papers), Healthcare Policy and Management (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Paul D. Light is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Healthcare Policy and Management (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Paul D. Light collaborates with scholars based in United States and Australia. Paul D. Light's co-authors include Jeffrey C. Fink, Vaughan H. Shoemaker, William R. Dawson, A. R. Main, Steven A. Blahut, Manoj Reddy, Nancy Armistead, Thomas C. Dowling, Thane Wibbels and Todd W.B. Gehr and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and Kidney International.

In The Last Decade

Paul D. Light

26 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul D. Light United States 14 292 182 158 123 121 26 871
James P. Dunn United States 18 64 0.2× 62 0.3× 86 0.5× 20 0.2× 5 0.0× 32 849
Kim M. Murray United States 14 17 0.1× 94 0.5× 39 0.2× 44 0.4× 3 0.0× 29 646
H. Bergmann Germany 15 20 0.1× 12 0.1× 147 0.9× 130 1.1× 7 0.1× 65 619
Richard Mackay New Zealand 17 38 0.1× 7 0.0× 55 0.3× 14 0.1× 13 0.1× 45 876
Xi Wang China 19 227 0.8× 21 0.1× 28 0.2× 2 0.0× 230 1.9× 94 1.1k
David F. Hardwick Canada 16 19 0.1× 6 0.0× 115 0.7× 24 0.2× 16 0.1× 66 1.1k
Björn Arvidsson Sweden 17 26 0.1× 63 0.3× 229 1.4× 118 1.0× 1 0.0× 39 1.3k
Richard E. Lee United States 13 5 0.0× 32 0.2× 93 0.6× 12 0.1× 21 0.2× 22 629
A.G. Hocken United Kingdom 13 55 0.2× 9 0.0× 14 0.1× 27 0.2× 15 0.1× 24 384
Samuel J. Moffitt United States 10 185 0.6× 42 0.2× 7 0.0× 110 0.9× 4 0.0× 16 1.1k

Countries citing papers authored by Paul D. Light

Since Specialization
Citations

This map shows the geographic impact of Paul D. Light's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Light with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Light more than expected).

Fields of papers citing papers by Paul D. Light

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Light. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Light. The network helps show where Paul D. Light may publish in the future.

Co-authorship network of co-authors of Paul D. Light

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Light. A scholar is included among the top collaborators of Paul D. Light based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Light. Paul D. Light is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Volpe, Donna A., Anne‐Marie Tobin, Fatemeh Tavakkoli, et al.. (2013). Effect of uremic serum and uremic toxins on drug metabolism in human microsomes. Regulatory Toxicology and Pharmacology. 68(2). 297–303. 29 indexed citations
2.
Weinman, Edward J., Paul D. Light, & Wadi N. Suki. (2013). Gastrointestinal Phosphate Handling in CKD and Its Association With Cardiovascular Disease. American Journal of Kidney Diseases. 62(5). 1006–1011. 15 indexed citations
3.
Light, Paul D.. (2006). Current understanding of optimal blood pressure goals in dialysis patients. Current Hypertension Reports. 8(5). 413–419. 4 indexed citations
4.
Henrich, William L., et al.. (2002). N-Terminal pro brain natriuretic peptide (NT-proBNP) predicts left ventricular function and mortality in hemodialysis patients but not cardiac death: a two-year outcome study. Journal of the American College of Cardiology. 39. 269–269. 1 indexed citations
5.
Tokars, Jerome I., Paul D. Light, John E. Anderson, et al.. (2001). A prospective study of vascular access infections at seven outpatient hemodialysis centers. American Journal of Kidney Diseases. 37(6). 1232–1240. 82 indexed citations
6.
Tokars, Jerome I., Todd W.B. Gehr, William R. Jarvis, et al.. (2001). Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers. Kidney International. 60(4). 1511–1516. 31 indexed citations
7.
Fink, Jeffrey C., et al.. (2001). Effect of Center- Versus Patient-Specific Factors on Variations in Dialysis Adequacy. Journal of the American Society of Nephrology. 12(1). 164–169. 18 indexed citations
8.
Fink, Jeffrey C., Steven A. Blahut, Manoj Reddy, & Paul D. Light. (2001). Use of Erythropoietin Before the Initiation of Dialysis and Its Impact on Mortality. American Journal of Kidney Diseases. 37(2). 348–355. 124 indexed citations
9.
10.
Fink, Jeffrey C., et al.. (1999). Significance of serum creatinine values in new end-stage renal disease patients. American Journal of Kidney Diseases. 34(4). 694–701. 59 indexed citations
11.
Fink, Jeffrey C., et al.. (1999). Hemodialysis adequacy in Network 5: Disparity between states and the role of center effects. American Journal of Kidney Diseases. 33(1). 97–104. 11 indexed citations
12.
Resnik, Charles S., et al.. (1997). Hemodialysis-related amyloidosis of the sternoclavicular joint. Skeletal Radiology. 26(7). 428–430. 4 indexed citations
13.
Light, Paul D., et al.. (1992). Hydroxysteroid Dehydrogenase Activity Associated with Sexual Differentiation in Embryos of the Turtle Trachemys Scripta1. Biology of Reproduction. 46(1). 140–145. 29 indexed citations
14.
Wibbels, Thane, et al.. (1992). Serum gonadotropins and gonadal steroids associated with ovulation and egg production in sea turtles. General and Comparative Endocrinology. 87(1). 71–78. 40 indexed citations
15.
Hall‐Craggs, Margaret, et al.. (1984). Development of immune complex nephritis during treatment with the calcium channel-blocking agent nifedipine. Human Pathology. 15(7). 691–694. 3 indexed citations
16.
Reed, William P., Paul D. Light, & John H. Sadler. (1984). Access for hemodialysis by means of long-term central venous catheters. Kidney International. 25(5). 838–840. 13 indexed citations
17.
Carpenter, William T., John H. Sadler, Paul D. Light, et al.. (1983). The Therapeutic Efficacy of Hemodialysis in Schizophrenia. New England Journal of Medicine. 308(12). 669–675. 19 indexed citations
18.
Light, Paul D., et al.. (1979). Relation between biological potency and clearance rates of gonadotropins in the lizard Anolis carolinensis. General and Comparative Endocrinology. 38(1). 21–27. 9 indexed citations
19.
Light, Paul D.. (1973). Relative potencies of purified mammalian gonadotropins on the uptake of radiophosphorus by chick testes. General and Comparative Endocrinology. 20(3). 592–594. 10 indexed citations
20.
Light, Paul D. & Anita K. Pearson. (1970). Failure of Parietalectomy to Affect the Testes in the Lizard Anolis carolinensis. Copeia. 1970(1). 172–172. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James P. Dunn Breakdown of academic impact, for papers by Kim M. Murray Breakdown of academic impact, for papers by H. Bergmann Breakdown of academic impact, for papers by Richard Mackay Breakdown of academic impact, for papers by Xi Wang Breakdown of academic impact, for papers by David F. Hardwick Breakdown of academic impact, for papers by Björn Arvidsson Breakdown of academic impact, for papers by Richard E. Lee Breakdown of academic impact, for papers by A.G. Hocken Breakdown of academic impact, for papers by Samuel J. Moffitt
Rankless by CCL
2026